|
|
||||||||
Ann Thorac Surg 2003;75:1624-1626
© 2003 The Society of Thoracic Surgeons
a Divisions of Division of Cardiovascular and Thoracic Surgery, Minneapolis, Minnesota, USA
b Division of and Cardiology, University of Minnesota, Minneapolis, Minnesota, USA
Accepted for publication October 21, 2002.
* Address reprint requests to Dr Liao, Division of Cardiovascular and Thoracic Surgery, University of Minnesota, Box 207, 420 Delaware St SE, Minneapolis, MN55455, USA (Email: liaox014{at}umn.edu).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Intraoperative transesophageal echocardiography (TEE) with bubble contrast study to detect PFO was performed in 16 consecutive patients receiving the HeartMate (Thoratec, Pleasanton, CA) VE LVAD between December 2000 and October 2001 at our institution. The surgical technique of LVAD implantation was similar to that described elsewhere [1], except that we routinely used bi-caval venous cannulation in preparation for possible PFO closure. In 14 patients, both pre–bypass and post LVAD TEE were performed. In the remaining 2 patients only post-LVAD TEE was performed and they were excluded from the study.
Our study protocol was as follows: (1) TEE was obtained before cardiopulmonary bypass and after LVAD activation. (2) Two-dimensional echocardiography was performed first with special attention paid to the atrial septum configuration and motion. (3) Then the bubble contrast study was performed. The contrast was created by injecting 10 mL of agitated Dextrose50 solution (Abbott Lab, Chicago, IL) into the right atrium. Appearance of microbubbles in the left atrium within three to four cardiac cycles was considered positive for PFO. (4) If PFO was detected, it was closed.
Intraoperative TEE in the 14 patients who were included in the study showed that the atrial septum was bulging toward the right atrium before cardiopulmonary bypass. However, after LVAD activation, the atrial septum was bulging toward the left atrium (Fig 1A, 1B). The bubble contrast study was negative for PFO when it was performed before bypass in these 14 patients, but it became positive in 3 of the same 14 patients when it was performed after LVAD activation (Fig 2A, 2B). All PFO detected by TEE were confirmed upon surgical exploration (sizes, 4 to 12 mm), and they were closed. The pre–bypass TEE missed all three surgically confirmed PFO. There were no complications related to PFO closure. None of these 14 patients experienced postoperative hypoxemia.
|
|
| Comment |
|---|
|
|
|---|
The severity of PFO induced hypoxemia is unpredictable. It is determined by the amount of right to left shunt, which can be affected by multiple factors such as the size of PFO, the pressure gradient between left and right atrium, and sometimes the redistribution of shunt flow related to atrial anatomic distortion. In patients with LVAD, the atrial pressure gradient may vary because of different preload conditions (volume status), and the direction of shunt flow may change because of the different gravity effects of the device when the body is at different positions. These may explain the characteristics of intermittent hypoxemia caused by PFO in LVAD patients [2, 3]. It is difficult to estimate the size of PFO or the extent of shunt by TEE. The amount of contrast microbubbles crossing the atrial septum does not necessarily correlate with the size of defect or the magnitude of shunt [3]. Once the PFO is detected, it should be treated as a large defect and closed during initial LVAD implantation.
Twenty-one percent of patients in this study were found to have PFO. With the increased application of LVAD, it is important to identify PFO and repair it during initial LVAD implantation to avoid postoperative hypoxemic complications.
Our study has demonstrated that the diagnosis of PFO by TEE in patients receiving LVAD can be made reliably only when LVAD is activated. Currently we adopt the protocol in our center that bi-caval venous cannulation was used routinely in patients receiving LVAD. Intraoperative TEE contrast study was performed immediately after LVAD was activated. If TEE study is positive for PFO, the heart is placed on total cardiopulmonary bypass and the PFO is closed with the heart being fibrillated. This approach adds minimal extra surgical complexity.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Writing Committee Members, G. S. Francis, B. H. Greenberg, D. T. Hsu, B. E. Jaski, M. Jessup, M. M. LeWinter, F. D. Pagani, I. L. Pina, M. J. Semigran, et al. ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant: A Report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training Circulation, August 10, 2010; 122(6): 644 - 672. [Full Text] [PDF] |
||||
![]() |
G. S. Francis, B. H. Greenberg, D. T. Hsu, B. E. Jaski, M. Jessup, M. M. LeWinter, F. D. Pagani, I. L. Pina, M. J. Semigran, M. N. Walsh, et al. ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant: A Report of the ACCF/AHA/ACP Task Force on Clinical Competence and Training J. Am. Coll. Cardiol., July 27, 2010; 56(5): 424 - 453. [Full Text] [PDF] |
||||
![]() |
S. Chumnanvej, M. J. Wood, T. E. MacGillivray, and M. F. V. Melo Perioperative Echocardiographic Examination for Ventricular Assist Device Implantation Anesth. Analg., September 1, 2007; 105(3): 583 - 601. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |